Xingwen Da

601 total citations
16 papers, 435 citations indexed

About

Xingwen Da is a scholar working on Molecular Biology, Surgery and Hematology. According to data from OpenAlex, Xingwen Da has authored 16 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Surgery and 4 papers in Hematology. Recurrent topics in Xingwen Da's work include Platelet Disorders and Treatments (3 papers), Aortic Disease and Treatment Approaches (2 papers) and Antiplatelet Therapy and Cardiovascular Diseases (2 papers). Xingwen Da is often cited by papers focused on Platelet Disorders and Treatments (3 papers), Aortic Disease and Treatment Approaches (2 papers) and Antiplatelet Therapy and Cardiovascular Diseases (2 papers). Xingwen Da collaborates with scholars based in China, United States and United Kingdom. Xingwen Da's co-authors include Yufeng Yao, Qixue Song, Changqing Hu, Aodi He, Zhangyin Ming, Qing K. Wang, Qiuyun Chen, Yubing Yu, Minglu Liang and Gang Liu and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Blood.

In The Last Decade

Xingwen Da

15 papers receiving 427 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xingwen Da China 11 201 92 82 56 51 16 435
Haizhao Yan China 12 265 1.3× 63 0.7× 92 1.1× 66 1.2× 86 1.7× 28 551
Moran Wang China 10 177 0.9× 101 1.1× 50 0.6× 52 0.9× 44 0.9× 25 508
Annalisa Contursi Italy 15 214 1.1× 77 0.8× 108 1.3× 184 3.3× 51 1.0× 31 567
Moua Yang United States 13 263 1.3× 81 0.9× 51 0.6× 35 0.6× 83 1.6× 34 527
Yakun Yang China 15 192 1.0× 37 0.4× 64 0.8× 85 1.5× 58 1.1× 46 590
Melissa Skibba United States 13 242 1.2× 62 0.7× 44 0.5× 35 0.6× 37 0.7× 21 547
Sara Tommasi Australia 13 167 0.8× 44 0.5× 78 1.0× 27 0.5× 32 0.6× 33 429
Ebru Alp Türkiye 16 276 1.4× 45 0.5× 169 2.1× 95 1.7× 47 0.9× 35 626
Guizhu Liu China 12 161 0.8× 65 0.7× 76 0.9× 59 1.1× 60 1.2× 22 428
William L. Willis United States 13 186 0.9× 61 0.7× 51 0.6× 55 1.0× 19 0.4× 16 392

Countries citing papers authored by Xingwen Da

Since Specialization
Citations

This map shows the geographic impact of Xingwen Da's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingwen Da with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingwen Da more than expected).

Fields of papers citing papers by Xingwen Da

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xingwen Da. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingwen Da. The network helps show where Xingwen Da may publish in the future.

Co-authorship network of co-authors of Xingwen Da

This figure shows the co-authorship network connecting the top 25 collaborators of Xingwen Da. A scholar is included among the top collaborators of Xingwen Da based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingwen Da. Xingwen Da is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Da, Xingwen, et al.. (2024). The natural flavonoid pinocembrin shows antithrombotic activity and suppresses septic thrombosis. International Immunopharmacology. 142(Pt B). 113237–113237.
2.
Wang, Jinxi, et al.. (2024). Glutamine Protects against Mouse Abdominal Aortic Aneurysm through Modulating VSMC Apoptosis and M1 Macrophage Activation. International Journal of Medical Sciences. 21(8). 1414–1427. 3 indexed citations
3.
Da, Xingwen, Ziyan Li, Xiaofan Huang, et al.. (2023). AGGF1 therapy inhibits thoracic aortic aneurysms by enhancing integrin α7-mediated inhibition of TGF-β1 maturation and ERK1/2 signaling. Nature Communications. 14(1). 2265–2265. 19 indexed citations
4.
Song, Qixue, Yubing Yu, Feng Liu, et al.. (2023). Protein therapy of skeletal muscle atrophy and mechanism by angiogenic factor AGGF1. Journal of Cachexia Sarcopenia and Muscle. 14(2). 978–991. 13 indexed citations
5.
Yu, Yubing, Yong Li, Huixin Peng, et al.. (2022). Angiogenic factor AGGF1 blocks neointimal formation after vascular injury via interaction with integrin α7 on vascular smooth muscle cells. Journal of Biological Chemistry. 298(4). 101759–101759. 10 indexed citations
6.
Yao, Yufeng, Qixue Song, Changqing Hu, et al.. (2021). Endothelial cell metabolic memory causes cardiovascular dysfunction in diabetes. Cardiovascular Research. 118(1). 196–211. 56 indexed citations
7.
Yao, Yufeng, Changqing Hu, Qixue Song, et al.. (2019). ADAMTS16 activates latent TGF-β, accentuating fibrosis and dysfunction of the pressure-overloaded heart. Cardiovascular Research. 116(5). 956–969. 94 indexed citations
8.
He, Aodi, Wei Song, Yuanyuan Ma, et al.. (2017). Platelet releasates promote the proliferation of hepatocellular carcinoma cells by suppressing the expression of KLF6. Scientific Reports. 7(1). 3989–3989. 49 indexed citations
9.
Da, Xingwen, et al.. (2017). Simvastatin prevents lipopolysaccharide-induced septic shock in rats. Journal of Huazhong University of Science and Technology [Medical Sciences]. 37(2). 226–230. 4 indexed citations
10.
Yao, Yufeng, Zhenkun Hu, Jian Ye, et al.. (2017). Targeting AGGF1 (angiogenic factor with G patch and FHA domains 1) for Blocking Neointimal Formation After Vascular Injury. Journal of the American Heart Association. 6(6). 22 indexed citations
11.
Yao, Yufeng, Qixue Song, Sisi Li, et al.. (2016). Up-regulation of miR-95-3p in hepatocellular carcinoma promotes tumorigenesis by targeting p21 expression. Scientific Reports. 6(1). 34034–34034. 38 indexed citations
12.
Xie, Wenlian, Aodi He, Xingwen Da, et al.. (2016). Antiplatelet activity of chrysin via inhibiting platelet αIIbβ3‐mediated signaling pathway. Molecular Nutrition & Food Research. 60(9). 1984–1993. 39 indexed citations
13.
Liang, Minglu, Xingwen Da, Aodi He, et al.. (2015). Pentamethylquercetin (PMQ) reduces thrombus formation by inhibiting platelet function. Scientific Reports. 5(1). 11142–11142. 29 indexed citations
14.
He, Aodi, Zhao Yin, Yajun Zhou, et al.. (2014). Antiplatelet activity of loureirin A by attenuating Akt phosphorylation: In vitro studies. European Journal of Pharmacology. 746. 63–69. 27 indexed citations
15.
He, Aodi, Minglu Liang, Gang Liu, et al.. (2014). The Role of FcγRIIa and TGF-β1/KLF6 Pathway in Platelet's Promoting Hepatocellular Carcinoma Cells Growth. Blood. 124(21). 1429–1429. 1 indexed citations
16.
Liu, Gang, Yajun Zhou, Yin Zhao, et al.. (2013). 2,3,5,4’-tetrahydroxystilbene-2-O-β-D-glucoside (THSG) attenuates human platelet aggregation, secretion and spreading in vitro. Thrombosis Research. 133(2). 211–217. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026